|
Showcases Products at Tashkent Medical Exhibition 2026, Expands CIS Market Outreach
2026.05.07
|
|---|
|
We announced that it participated in the “Tashkent International Healthcare Exhibition 2026,” held from April 28 to 30 in Tashkent, Uzbekistan, where it showcased a range of products and engaged with local buyers to strengthen its presence in the Central Asian market. The company has already registered several products, including Luthione injection, with the Uzbek regulatory authority and is actively exporting to the country. During the exhibition, We met with potential buyers not only from Uzbekistan but also from neighboring CIS countries, introducing its product portfolio and exploring new business opportunities. Pharmaceutical trends in the CIS region have recently been shifting beyond basic treatments toward non-reimbursable wellness injectables and clinic-specialized products. We focused its promotion on these products, where it holds a competitive edge over other pharmaceutical companies, receiving an enthusiastic response from local medical professionals and distributors. In particular, following the recent tightening of pharmaceutical registration regulations in Uzbekistan, closer collaboration with local partners and thorough preparation of regulatory documentation have become increasingly important. The company focused on discussing these key issues with local partners during the event to further refine its market entry strategy. The Tashkent International Healthcare Exhibition is regarded as the largest healthcare exhibition in the CIS region, attracting numerous pharmaceutical and medical device companies worldwide, and is considered a key platform for entering the CIS market. |


Home